FI92058C - Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi Download PDF

Info

Publication number
FI92058C
FI92058C FI901883A FI901883A FI92058C FI 92058 C FI92058 C FI 92058C FI 901883 A FI901883 A FI 901883A FI 901883 A FI901883 A FI 901883A FI 92058 C FI92058 C FI 92058C
Authority
FI
Finland
Prior art keywords
nco
substituted
piperazine
preparation
ethanol
Prior art date
Application number
FI901883A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI92058B (fi
FI901883A0 (fi
Inventor
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Eduardo Pirotzky
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of FI901883A0 publication Critical patent/FI901883A0/fi
Publication of FI92058B publication Critical patent/FI92058B/fi
Application granted granted Critical
Publication of FI92058C publication Critical patent/FI92058C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI901883A 1989-04-15 1990-04-12 Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi FI92058C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
GB8908587 1989-04-15

Publications (3)

Publication Number Publication Date
FI901883A0 FI901883A0 (fi) 1990-04-12
FI92058B FI92058B (fi) 1994-06-15
FI92058C true FI92058C (fi) 1994-09-26

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901883A FI92058C (fi) 1989-04-15 1990-04-12 Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi

Country Status (32)

Country Link
US (1) US5019576A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2633709B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR900016178A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR247736A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT399337B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU631334B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1007245A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2014521C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH681301A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4011925A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK91890A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DZ (1) DZ1407A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2019554A6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI92058C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2645859B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB8908587D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR1000355B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK95092A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE65058B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN175799B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1241631B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU87719A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA21805A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL9000798A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO176098C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ233250A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA09446A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT93736B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE505186C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG92092G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN90051A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA902566B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
BR9608245A (pt) * 1995-05-02 1999-05-04 Schering Corp Derivados de piperazino como antagonistas de neurocinina
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4937246A (en) * 1987-11-25 1990-06-26 Takeda Chemical Industries, Ltd. PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof
EP0343900A3 (en) * 1988-05-23 1991-07-03 Glaxo Group Limited Piperazine compounds
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
IE901314L (en) 1990-10-15
IT9020020A1 (it) 1991-10-12
AT399337B (de) 1995-04-25
SE505186C2 (sv) 1997-07-14
FI92058B (fi) 1994-06-15
US5019576A (en) 1991-05-28
NO901631L (no) 1990-10-16
GB2230262B (en) 1992-02-26
GB8908587D0 (en) 1989-06-01
ES2019554A6 (es) 1991-06-16
NO176098C (no) 1995-02-01
DE4011925A1 (de) 1990-10-18
AU5326190A (en) 1990-11-01
JPH02292266A (ja) 1990-12-03
DK91890A (da) 1990-10-16
GB2230262A (en) 1990-10-17
JP2633709B2 (ja) 1997-07-23
ATA86690A (de) 1994-09-15
KR900016178A (ko) 1990-11-12
GR900100270A (en) 1991-09-27
FI901883A0 (fi) 1990-04-12
GB9007612D0 (en) 1990-05-30
CH681301A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-02-26
SE9001269L (sv) 1990-10-16
AR247736A1 (es) 1995-03-31
MA21805A1 (fr) 1990-12-31
IT1241631B (it) 1994-01-25
IE65058B1 (en) 1995-10-04
HK95092A (en) 1992-12-04
BE1007245A3 (fr) 1995-05-02
NZ233250A (en) 1991-03-26
IT9020020A0 (it) 1990-04-12
LU87719A1 (fr) 1990-07-24
DK91890D0 (da) 1990-04-11
DZ1407A1 (fr) 2004-09-13
NO901631D0 (no) 1990-04-10
FR2645859A1 (fr) 1990-10-19
TNSN90051A1 (fr) 1991-03-05
ZA902566B (en) 1991-01-30
FR2645859B1 (fr) 1992-06-05
AU631334B2 (en) 1992-11-19
CA2014521A1 (en) 1990-10-15
PT93736A (pt) 1990-11-20
SG92092G (en) 1992-12-04
CA2014521C (en) 1997-09-09
OA09446A (fr) 1992-10-15
NL9000798A (nl) 1990-11-01
SE9001269D0 (sv) 1990-04-06
FR2645743A1 (fr) 1990-10-19
FR2645743B1 (fr) 1992-06-05
GR1000355B (el) 1992-06-25
PT93736B (pt) 1996-09-30
NO176098B (no) 1994-10-24
IN175799B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-08-26

Similar Documents

Publication Publication Date Title
Artis et al. Oxidative radical cyclization of (. omega.-iodoalkyl) indoles and pyrroles. synthesis of (-)-monomorine and three diastereomers
EP2562168B1 (en) Therapeutic piperazines as pde4 inhibitors
FI92058C (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
EP0873320A1 (en) Piperazine derivatives as tachykinin antagonists
JPH02191281A (ja) 新規チエノ―トリアゾロ―１，４―ジアゼピノ―２―カルボン酸
EP1641758A2 (fr) Derives de diphenylpyridine, leur preparation et leur application en therapeutique
KR20080089413A (ko) 카나비노이드 ｃｂ1 수용체 조절자로서의4,5-디하이드로-(1ｈ)-피라졸 유도체
WO2005080357A2 (fr) Derives d’oxazole, leur preparation et leur utilisation en therapeutique
Shin et al. α, β-Unsaturated Carboxylic Acid Derivatives. IV. General Synthesis of Unsaturated Unsymmetric 3, 6-Disubstituted-2, 5-piperazinediones
WO2005035488A2 (fr) Derives de thiophene-2-carboxamide et leurs utilisation comme antagonistes des recepteurs cb1 des cannabinoides
Manhas et al. Heterocyclic compounds. VII. Synthesis of thiadiazasteroid analogs
FI111943B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen enantiomeerisen yhdisteen valmistamiseksi, joka on (S)- tai (R)-2-[3-[4-(3-kloorifenyyli)-1-(2-alkyyli)-piperatsinyyli]propyyli]-1,2,4-triatsolo[4,3-a]pyridin-3-(2H)-oni, ja välituotteet
CN101268043A (zh) 作为ccr3受体配体的氨基-烷基-酰胺衍生物
JPH05507732A (ja) イソオキサゾリルイミダゾール誘導体、その製造法およびその医薬への使用
Pocar et al. v‐Triazolines. XXXIX. 1, 2, 4‐Triaryl‐3‐aminopyrroles. Unusual Reaction Products in the Pyrolysis of 5‐Amino‐v‐triazolines and the Crystal Structure of 2‐(3‐Morpholin‐4‐yl‐2, 4‐pyrrol‐1‐yl) benzonitrile
FI65621C (fi) Foerfarande foer framstaellning av som cns-aktiva medel anvaendbara 2-(4,4-difluorfenyl-butyl)-6h-oktahydropyrazino-(1,2-c) pyrimidin-6-oner
Földényi et al. Heterocyclic derivatives of 2-amino-4-nitrophenol
Shin et al. Approaches to the Syntheses of Partially Reduced Imidazo [1, 2-a] pyridines
HK1185063B (en) Therapeutic piperazines as pde4 inhibitors
EP2212285A1 (en) N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
HK1052929A1 (en) Process for preparing arylacetylaminothiazoles
HK1052929B (en) Process for preparing arylacetylaminothiazoles

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION